Geron, the first company to have an embryonic stem cell clinical trial approved by the FDA, is closing the trial in order to focus its efforts (and $$$) on cancer therapies. Hmmm...so that's a bummer. Obviously, more people suffer from cancer than from SCI so the market to recoup R&D dollars is bigger, but for such a high profile, famous trial to pull the plug is disheartening and can't be good PR for the Cure SCI movement.
Silver lining? There are plenty of other therapies progressing everyday, now research monies and charitable gifts won't continue going to a therapy that doesn't work, etc., but this still hurts.
To cheer you up:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment